Arrowhead Pharmaceuticals
ARWR
#3876
Rank
A$3.91 B
Marketcap
$31.07
Share price
-5.06%
Change (1 day)
-30.21%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): -$2.58

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.65. In 2022 the company made an earnings per share (EPS) of -$2.28 an increase over its 2021 EPS that were of -$2.75.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.5813.26%
2022-$2.28-17.05%
2021-$2.7574.26%
2020-$1.58-283.64%
2019$0.86-257.14%
2018-$0.55-27.08%
2017-$0.75-59.32%
2016-$1.84-21.85%
2015-$2.369.42%
2014-$2.152.87%
2013-$2.09-31.56%
2012-$3.06300%
2011-$0.77-45.56%
2010-$1.41-66.67%
2009-$4.22-63.51%
2008-$11.56-12.94%
2007-$13.2744.07%
2006-$9.2177.35%
2005-$5.1910.66%
2004-$4.69-54.25%
2003-$10.26-80.51%
2002-$52.653.87%
2001-$50.69116.17%
2000-$23.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.42 141.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.45-192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.01-61.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.99-928.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-$14.27 437.65%๐Ÿ‡บ๐Ÿ‡ธ USA